Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1h-3-benzazepine-7,8-diol, 2,3,4,5-tetrahydro-1-phenyl-
2. 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1h-3-benzazepine
3. R-sk And F 38393
4. Rsk And F 38393
5. Sk And F 38393
6. Sk And F-38393
7. Sk And F38393
8. Skf 38393
9. Skf 38393 A
10. Skf 38393-a
11. Skf 38393a
12. Skf-38393
13. Skf38393
1. 62717-42-4
2. Skf 38393 Hydrochloride
3. Skf38393 Hcl
4. Skf-38393 Hydrochloride
5. Skf 38393 (hydrochloride)
6. (+/-)-skf-38393 Hydrochloride
7. Skf-38393 Hcl
8. Skf-38393a
9. Wiv5r2g7vp
10. 1h-3-benzazepine-7,8-diol, 2,3,4,5-tetrahydro-1-phenyl-, Hydrochloride
11. 2-phenyl-4-azabicyclo[5.4.0]undeca-7,9,11-triene-9,10-diol
12. (r)-skf 38393 (hydrochloride)
13. Nsc-320959
14. 81633-77-4
15. 62717-42-4 (hcl)
16. 2,3,4,5-tetrahydro-1-phenyl-1h-3-benzazepine-7,8-diol Hydrochloride
17. (+/-)-1-phenyl-2,3,4,5-tetrahydro-(1h)-3-benzazepine-7,8-diol Hydrochloride
18. (+/-)-skf-38393 Hydrochloride;skf-38393a
19. Chembl542700
20. Sr-01000075378
21. Skf 38393a
22. Unii-wiv5r2g7vp
23. Skf-38393hydrochloride
24. C16h17no2.hcl
25. Mls000859931
26. Skf 38393 Hcl
27. Schembl3425787
28. (y)-skf-38393 Hydrochloride
29. Dtxsid20936175
30. (?)-skf-38393 Hydrochloride
31. Bcp28880
32. Ex-a3563
33. Tox21_500436
34. 1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine-7,8-diol Hydrochloride
35. Hy-12520a
36. Nsc320959
37. Akos016012197
38. Ccg-221740
39. Cs-5354
40. Lp00436
41. Nsc 320959
42. Ncgc00093856-01
43. Ncgc00261121-01
44. Ac-32754
45. As-16874
46. Smr000326792
47. D-047
48. Eu-0100436
49. S7993
50. (+/-)-skf-38393 Hydrochloride, Crystalline
51. C75947
52. ( Inverted Question Mark)-skf-38393 Hydrochloride
53. Sr-01000075378-1
54. ( Inverted Exclamation Marka)-skf38393 Hydrochloride
55. ( Inverted Exclamation Marka)-skf-38393 Hydrochloride
56. (+/-)-skf-38393 Hydrochloride D1 Dopamin E Receptor
57. (+/-)-skf-38393 Hydrochloride, Crystalline, >=98% (hplc)
58. (+/-)-1-phenyl-2,3,4-tetrahydro(1h)-3-benzapezine-7,8-diol Hcl
59. 5-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine-7,8-diol;hydrochloride
60. (+/-)-1-phenyl-2,3,4,5-tetrahydro-(1h)-3-benzazepine-7,8- Diol Hydrobromide
61. (+/-)-1-phenyl-2,3,4-tetrahydro(1h)-3-benzapezine-7,8-diol Hydrochloride
62. 1h-3-benzazepine-7,8-diol, 2,3,4,5-tetrahydro-1-phenyl-, Hydrochloride (1:1)
63. 1h-3-benzazepine-7,8-diol, 2,3,4,5-tetrahydro-1-phenyl-,?hydrochloride (1:1)
64. ( Inverted Question Mark)-1-phenyl-2,3,4,5-tetrahydro-(1h)-3-benzazepine-7,8-diol Hydrochloride
| Molecular Weight | 291.77 g/mol |
|---|---|
| Molecular Formula | C16H18ClNO2 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 1 |
| Exact Mass | 291.1026065 g/mol |
| Monoisotopic Mass | 291.1026065 g/mol |
| Topological Polar Surface Area | 52.5 Ų |
| Heavy Atom Count | 20 |
| Formal Charge | 0 |
| Complexity | 291 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Dopamine Agonists
Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)
ABOUT THIS PAGE
88
PharmaCompass offers a list of Benzazepine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Benzazepine manufacturer or Benzazepine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Benzazepine manufacturer or Benzazepine supplier.
PharmaCompass also assists you with knowing the Benzazepine API Price utilized in the formulation of products. Benzazepine API Price is not always fixed or binding as the Benzazepine Price is obtained through a variety of data sources. The Benzazepine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Benzazepine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Benzazepine, including repackagers and relabelers. The FDA regulates Benzazepine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Benzazepine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Benzazepine supplier is an individual or a company that provides Benzazepine active pharmaceutical ingredient (API) or Benzazepine finished formulations upon request. The Benzazepine suppliers may include Benzazepine API manufacturers, exporters, distributors and traders.
click here to find a list of Benzazepine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Benzazepine DMF (Drug Master File) is a document detailing the whole manufacturing process of Benzazepine active pharmaceutical ingredient (API) in detail. Different forms of Benzazepine DMFs exist exist since differing nations have different regulations, such as Benzazepine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Benzazepine DMF submitted to regulatory agencies in the US is known as a USDMF. Benzazepine USDMF includes data on Benzazepine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Benzazepine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Benzazepine suppliers with USDMF on PharmaCompass.
Benzazepine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Benzazepine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Benzazepine GMP manufacturer or Benzazepine GMP API supplier for your needs.
A Benzazepine CoA (Certificate of Analysis) is a formal document that attests to Benzazepine's compliance with Benzazepine specifications and serves as a tool for batch-level quality control.
Benzazepine CoA mostly includes findings from lab analyses of a specific batch. For each Benzazepine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Benzazepine may be tested according to a variety of international standards, such as European Pharmacopoeia (Benzazepine EP), Benzazepine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Benzazepine USP).
